Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CSTL vs $FLGT | Chartloom

Compare

$CSTL vs $FLGT

Castle Biosciences Inc · Fulgent Genetics Inc

CSTL

Castle Biosciences Inc

FLGT

Fulgent Genetics Inc

Compare $CSTL vs $FLGT

Comparing Castle Biosciences Inc and Fulgent Genetics Inc

CSTLCastle Biosciences Inc

FLGTFulgent Genetics Inc

CSTLCastle Biosciences Inc

Market cap

$1.00B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.57x

Rev growth (TTM)

3.2%

YTD performance

-14.1%

52W performance

45.2%

FCF yield

-0.0%

FLGTFulgent Genetics Inc

Market cap

$597M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.62x

Rev growth (TTM)

6.8%

YTD performance

-17.9%

52W performance

-6.6%

FCF yield

-17.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CSTL

FLGT

Detailed metrics comparison

CSTL

Castle Biosciences Inc

FLGT

Fulgent Genetics Inc

Market Cap

CSTL$1.00B

FLGT$597M

Enterprise Value

CSTL$952M

FLGT$574M

Price

CSTL$33.11

FLGT$21.01

P/E Ratio

CSTLN/A

FLGTN/A

P/S Ratio

CSTL2.81x

FLGT1.84x

EV/Sales

CSTL2.67x

FLGT1.77x

EV/EBITDA

CSTL242.60x

FLGT3.11x

P/B Ratio

CSTL2.24x

FLGT0.60x

P/FCF Ratio

CSTLN/A

FLGTN/A

EV/FCF

CSTL-1,947.75x

FLGT-5.53x

PEG Ratio

CSTLN/A

FLGTN/A

Forward P/E (NTM)

CSTLN/A

FLGTN/A

Forward P/S (NTM)

CSTL2.57x

FLGT1.62x

Revenue (TTM)

CSTL$357M

FLGT$324M

Revenue Growth (YoY)

CSTL3.2%

FLGT6.8%

Forward Rev Growth

CSTL9.6%

FLGT15.4%

Gross Margin (TTM)

CSTL77.3%

FLGT35.6%

Operating Margin (TTM)

CSTL0.0%

FLGT0.0%

EBITDA Margin (TTM)

CSTL-4.6%

FLGT-29.1%

Net Margin (TTM)

CSTL-5.4%

FLGT-26.0%

FCF Margin (TTM)

CSTL-0.1%

FLGT-32.0%

Net Income (TTM)

CSTL$-19M

FLGT$-84M

FCF (TTM)

CSTL$-489K

FLGT$-104M

EPS (TTM)

CSTL-$0.64

FLGT-$3.01

ROE (TTM)

CSTL-415.0%

FLGT-787.0%

ROA (TTM)

CSTL-345.0%

FLGT-722.0%

ROIC (TTM)

CSTL-406.0%

FLGT-785.0%

Cash

CSTL$62M

FLGT$26M

Debt

CSTL$10M

FLGT$4M

Net Cash/Debt

CSTL$52M

FLGT$22M

Current Ratio (TTM)

CSTL6.04x

FLGT6.34x

Quick Ratio (TTM)

CSTL5.58x

FLGT4.72x

Debt/Equity (TTM)

CSTL0.02x

FLGT0.00x

Debt/Assets (TTM)

CSTL0.0%

FLGT0.0%

Interest Coverage (TTM)

CSTLN/A

FLGTN/A

Net Debt/EBITDA (TTM)

CSTL0.00x

FLGT0.00x

Beta

CSTL0.99

FLGT1.03

52W Performance

CSTL45.2%

FLGT-6.6%

YTD Performance

CSTL-14.1%

FLGT-17.9%

% from 52W High

CSTL-25.2%

FLGT-32.3%

% from 52W Low

CSTL86.8%

FLGT56.1%

Asset Turnover (TTM)

CSTL0.64x

FLGT0.28x

FCF Yield (TTM)

CSTL-0.0%

FLGT-17.4%

Earnings Yield (TTM)

CSTL-1.9%

FLGT-14.1%

Dividend Yield (TTM)

CSTLN/A

FLGTN/A

Rule of 40

CSTL3.0

FLGT-25.2

EV/GP/RG

CSTL0.29

FLGT0.03

Ticker research

View CSTL research View FLGT research

Metric	CSTL Castle Biosciences Inc	FLGT Fulgent Genetics Inc
Market & Valuation
Market Cap	$1.00B	$597M
Enterprise Value	$952M	$574M
Price	$33.11	$21.01
P/E Ratio	N/A	N/A
P/S Ratio	2.81x	1.84x
EV/Sales	2.67x	1.77x
EV/EBITDA	242.60x	3.11x
P/B Ratio	2.24x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1,947.75x	-5.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.57x	1.62x
Revenue & Growth
Revenue (TTM)	$357M	$324M
Revenue Growth (YoY)	3.2%	6.8%
Forward Rev Growth	9.6%	15.4%
Profitability
Gross Margin (TTM)	77.3%	35.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4.6%	-29.1%
Net Margin (TTM)	-5.4%	-26.0%
FCF Margin (TTM)	-0.1%	-32.0%
Net Income (TTM)	$-19M	$-84M
FCF (TTM)	$-489K	$-104M
EPS (TTM)	-$0.64	-$3.01
ROE (TTM)	-415.0%	-787.0%
ROA (TTM)	-345.0%	-722.0%
ROIC (TTM)	-406.0%	-785.0%
Financial Health
Cash	$62M	$26M
Debt	$10M	$4M
Net Cash/Debt	$52M	$22M
Current Ratio (TTM)	6.04x	6.34x
Quick Ratio (TTM)	5.58x	4.72x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	1.03
52W Performance	45.2%	-6.6%
YTD Performance	-14.1%	-17.9%
% from 52W High	-25.2%	-32.3%
% from 52W Low	86.8%	56.1%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	0.28x
FCF Yield (TTM)	-0.0%	-17.4%
Earnings Yield (TTM)	-1.9%	-14.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-25.2
EV/GP/RG	0.29	0.03
Ticker research	View CSTL research	View FLGT research

Valuation

P/S Ratio

FLGT

1.84x

CSTL

2.81x

EV/FCF

CSTL

-1,947.75x

FLGT

-5.53x

Growth & revenue

Revenue Growth TTM

FLGT

6.8%

CSTL

3.2%

Forward Revenue Growth

FLGT

15.4%

CSTL

9.6%

Profitability & performance

Gross Margin

CSTL

77.3%

FLGT

35.6%

ROE

CSTL

-415.0%

FLGT

-787.0%

FCF Yield %

CSTL

-0.0%

FLGT

-17.4%

52-Week Performance

CSTL

45.2%

FLGT

-6.6%

Detailed metrics comparison

CSTL

Castle Biosciences Inc

FLGT

Fulgent Genetics Inc

Market Cap

CSTL$1.00B

FLGT$597M

Enterprise Value

CSTL$952M

FLGT$574M

Price

CSTL$33.11

FLGT$21.01

P/E Ratio

CSTLN/A

FLGTN/A

P/S Ratio

CSTL2.81x

FLGT1.84x

EV/Sales

CSTL2.67x

FLGT1.77x

EV/EBITDA

CSTL242.60x

FLGT3.11x

P/B Ratio

CSTL2.24x

FLGT0.60x

P/FCF Ratio

CSTLN/A

FLGTN/A

EV/FCF

CSTL-1,947.75x

FLGT-5.53x

PEG Ratio

CSTLN/A

FLGTN/A

Forward P/E (NTM)

CSTLN/A

FLGTN/A

Forward P/S (NTM)

CSTL2.57x

FLGT1.62x

Revenue (TTM)

CSTL$357M

FLGT$324M

Revenue Growth (YoY)

CSTL3.2%

FLGT6.8%

Forward Rev Growth

CSTL9.6%

FLGT15.4%

Gross Margin (TTM)

CSTL77.3%

FLGT35.6%

Operating Margin (TTM)

CSTL0.0%

FLGT0.0%

EBITDA Margin (TTM)

CSTL-4.6%

FLGT-29.1%

Net Margin (TTM)

CSTL-5.4%

FLGT-26.0%

FCF Margin (TTM)

CSTL-0.1%

FLGT-32.0%

Net Income (TTM)

CSTL$-19M

FLGT$-84M

FCF (TTM)

CSTL$-489K

FLGT$-104M

EPS (TTM)

CSTL-$0.64

FLGT-$3.01

ROE (TTM)

CSTL-415.0%

FLGT-787.0%

ROA (TTM)

CSTL-345.0%

FLGT-722.0%

ROIC (TTM)

CSTL-406.0%

FLGT-785.0%

Cash

CSTL$62M

FLGT$26M

Debt

CSTL$10M

FLGT$4M

Net Cash/Debt

CSTL$52M

FLGT$22M

Current Ratio (TTM)

CSTL6.04x

FLGT6.34x

Quick Ratio (TTM)

CSTL5.58x

FLGT4.72x

Debt/Equity (TTM)

CSTL0.02x

FLGT0.00x

Debt/Assets (TTM)

CSTL0.0%

FLGT0.0%

Interest Coverage (TTM)

CSTLN/A

FLGTN/A

Net Debt/EBITDA (TTM)

CSTL0.00x

FLGT0.00x

Beta

CSTL0.99

FLGT1.03

52W Performance

CSTL45.2%

FLGT-6.6%

YTD Performance

CSTL-14.1%

FLGT-17.9%

% from 52W High

CSTL-25.2%

FLGT-32.3%

% from 52W Low

CSTL86.8%

FLGT56.1%

Asset Turnover (TTM)

CSTL0.64x

FLGT0.28x

FCF Yield (TTM)

CSTL-0.0%

FLGT-17.4%

Earnings Yield (TTM)

CSTL-1.9%

FLGT-14.1%

Dividend Yield (TTM)

CSTLN/A

FLGTN/A

Rule of 40

CSTL3.0

FLGT-25.2

EV/GP/RG

CSTL0.29

FLGT0.03

Ticker research

View CSTL research View FLGT research

Metric	CSTL Castle Biosciences Inc	FLGT Fulgent Genetics Inc
Market & Valuation
Market Cap	$1.00B	$597M
Enterprise Value	$952M	$574M
Price	$33.11	$21.01
P/E Ratio	N/A	N/A
P/S Ratio	2.81x	1.84x
EV/Sales	2.67x	1.77x
EV/EBITDA	242.60x	3.11x
P/B Ratio	2.24x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1,947.75x	-5.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.57x	1.62x
Revenue & Growth
Revenue (TTM)	$357M	$324M
Revenue Growth (YoY)	3.2%	6.8%
Forward Rev Growth	9.6%	15.4%
Profitability
Gross Margin (TTM)	77.3%	35.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4.6%	-29.1%
Net Margin (TTM)	-5.4%	-26.0%
FCF Margin (TTM)	-0.1%	-32.0%
Net Income (TTM)	$-19M	$-84M
FCF (TTM)	$-489K	$-104M
EPS (TTM)	-$0.64	-$3.01
ROE (TTM)	-415.0%	-787.0%
ROA (TTM)	-345.0%	-722.0%
ROIC (TTM)	-406.0%	-785.0%
Financial Health
Cash	$62M	$26M
Debt	$10M	$4M
Net Cash/Debt	$52M	$22M
Current Ratio (TTM)	6.04x	6.34x
Quick Ratio (TTM)	5.58x	4.72x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	1.03
52W Performance	45.2%	-6.6%
YTD Performance	-14.1%	-17.9%
% from 52W High	-25.2%	-32.3%
% from 52W Low	86.8%	56.1%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	0.28x
FCF Yield (TTM)	-0.0%	-17.4%
Earnings Yield (TTM)	-1.9%	-14.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-25.2
EV/GP/RG	0.29	0.03
Ticker research	View CSTL research	View FLGT research